Global CAR-T Cell Therapy Drugs Market Growth (Status and Outlook) 2026-2032
The global CAR-T Cell Therapy Drugs market size is predicted to grow from US$ 3977 million in 2025 to US$ 7747 million in 2032; it is expected to grow at a CAGR of 10.2% from 2026 to 2032.
CAR-T cell therapy is a personalized live cell therapy based on genetically engineered T cells from a patient. The patient's T cells are extracted in vitro and the chimeric antigen receptor (CAR) gene is introduced using viral or non-viral vectors, giving them the ability to specifically recognize and attack tumor cells. After in vitro expansion, these cells are reinfused into the patient, achieving precise immune clearance of hematologic malignancies and even some solid tumors. This therapy is essentially a 'living drug,' possessing the triple attributes of cell therapy, gene therapy, and immunotherapy.
The CAR-T industry chain can be divided into three main segments: upstream core raw materials and technology platforms, midstream cell therapy development and manufacturing, and downstream clinical application and commercialization. The upstream segment includes key consumables and tools such as viral vectors, plasmid DNA, cell culture media, disposable bioreactors, automated closed cell preparation equipment, and quality control reagents. The midstream segment encompasses CAR gene design and optimization, T cell collection, gene transduction, cell expansion, quality control, and GMP-level production systems. The downstream segment involves patient screening, lymph node dissection chemotherapy, cell reinfusion, and adverse reaction management in hospital hematology/oncology centers. It also involves medical insurance payments, commercial insurance, and high-value drug access systems, forming a closed-loop ecosystem of 'patient customization + highly GMP manufacturing + high-barrier medical services.'
The CAR-T industry is at a critical inflection point, transitioning from 'breakthrough therapy for hematologic malignancies' to 'expansion into solid tumors and autoimmune diseases.' Future growth will be driven by expanding indications, technological upgrades, reduced manufacturing costs, and the gradual liberalization of global payment systems. With the maturation of automated production, non-viral vector technologies, and large-scale CDMO systems, CAR-T is expected to gradually move from the current ultra-high-cost 'personalized customized therapy' to 'quasi-large-scale biologics.' The long-term market potential is projected to exceed tens of billions of US dollars, and it will form a competitive and complementary relationship with bispecific antibodies, TCR-T, and ADCs in tumor immunotherapy.
United States market for CAR-T Cell Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CAR-T Cell Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CAR-T Cell Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CAR-T Cell Therapy Drugs players cover Novartis, Kite Pharma, Bristol Myers Squibb?BMS?, Gilead Sciences, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?CAR-T Cell Therapy Drugs Industry Forecast? looks at past sales and reviews total world CAR-T Cell Therapy Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Cell Therapy Drugs sales for 2026 through 2032. With CAR-T Cell Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Cell Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Cell Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Cell Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CAR-T Cell Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Cell Therapy Drugs and breaks down the forecast by Targets, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Cell Therapy Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Targets:
CAR-T cell therapy is a personalized live cell therapy based on genetically engineered T cells from a patient. The patient's T cells are extracted in vitro and the chimeric antigen receptor (CAR) gene is introduced using viral or non-viral vectors, giving them the ability to specifically recognize and attack tumor cells. After in vitro expansion, these cells are reinfused into the patient, achieving precise immune clearance of hematologic malignancies and even some solid tumors. This therapy is essentially a 'living drug,' possessing the triple attributes of cell therapy, gene therapy, and immunotherapy.
The CAR-T industry chain can be divided into three main segments: upstream core raw materials and technology platforms, midstream cell therapy development and manufacturing, and downstream clinical application and commercialization. The upstream segment includes key consumables and tools such as viral vectors, plasmid DNA, cell culture media, disposable bioreactors, automated closed cell preparation equipment, and quality control reagents. The midstream segment encompasses CAR gene design and optimization, T cell collection, gene transduction, cell expansion, quality control, and GMP-level production systems. The downstream segment involves patient screening, lymph node dissection chemotherapy, cell reinfusion, and adverse reaction management in hospital hematology/oncology centers. It also involves medical insurance payments, commercial insurance, and high-value drug access systems, forming a closed-loop ecosystem of 'patient customization + highly GMP manufacturing + high-barrier medical services.'
The CAR-T industry is at a critical inflection point, transitioning from 'breakthrough therapy for hematologic malignancies' to 'expansion into solid tumors and autoimmune diseases.' Future growth will be driven by expanding indications, technological upgrades, reduced manufacturing costs, and the gradual liberalization of global payment systems. With the maturation of automated production, non-viral vector technologies, and large-scale CDMO systems, CAR-T is expected to gradually move from the current ultra-high-cost 'personalized customized therapy' to 'quasi-large-scale biologics.' The long-term market potential is projected to exceed tens of billions of US dollars, and it will form a competitive and complementary relationship with bispecific antibodies, TCR-T, and ADCs in tumor immunotherapy.
United States market for CAR-T Cell Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CAR-T Cell Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CAR-T Cell Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CAR-T Cell Therapy Drugs players cover Novartis, Kite Pharma, Bristol Myers Squibb?BMS?, Gilead Sciences, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?CAR-T Cell Therapy Drugs Industry Forecast? looks at past sales and reviews total world CAR-T Cell Therapy Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Cell Therapy Drugs sales for 2026 through 2032. With CAR-T Cell Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Cell Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Cell Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Cell Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CAR-T Cell Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Cell Therapy Drugs and breaks down the forecast by Targets, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Cell Therapy Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Targets:
- CD19 CAR-T
- BCMA CAR-T
- CD22 CAR-T
- Dual-target CAR-T
- Autologous CAR-T
- Universal CAR-T
- Hematologic Malignancies
- Solid Tumors
- Autoimmune Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Kite Pharma
- Bristol Myers Squibb?BMS?
- Gilead Sciences
- Johnson & Johnson
- Legend Biotech
- Fosun Kite
- JW Therapeutics
- IASO Biotherapeutics
- Juventas Cell Therapy
- CARsgen Therapeutics
- Bluebird Bio
- Curocell
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Cell Therapy Drugs Market Size (2021-2032)
2.1.2 CAR-T Cell Therapy Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-T Cell Therapy Drugs by Country/Region (2021, 2025 & 2032)
2.2 CAR-T Cell Therapy Drugs Segment by Targets
2.2.1 CD19 CAR-T
2.2.2 BCMA CAR-T
2.2.3 CD22 CAR-T
2.2.4 Dual-target CAR-T
2.2.5 CAR-T Cell Therapy Drugs Market Size by Targets
2.2.5.1 CAR-T Cell Therapy Drugs Market Size CAGR by Targets (2021 VS 2025 VS 2032)
2.2.5.2 Global CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
2.3 CAR-T Cell Therapy Drugs Segment by Cell Origin
2.3.1 Autologous CAR-T
2.3.2 Universal CAR-T
2.3.3 CAR-T Cell Therapy Drugs Market Size by Cell Origin
2.3.3.1 CAR-T Cell Therapy Drugs Market Size CAGR by Cell Origin (2021 VS 2025 VS 2032)
2.3.3.2 Global CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2021-2026)
2.4 CAR-T Cell Therapy Drugs Segment by Application
2.4.1 Hematologic Malignancies
2.4.2 Solid Tumors
2.4.3 Autoimmune Diseases
2.4.4 CAR-T Cell Therapy Drugs Market Size by Application
2.4.4.1 CAR-T Cell Therapy Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.4.2 Global CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
3 CAR-T CELL THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 CAR-T Cell Therapy Drugs Market Size Market Share by Player
3.1.1 Global CAR-T Cell Therapy Drugs Revenue by Player (2021-2026)
3.1.2 Global CAR-T Cell Therapy Drugs Revenue Market Share by Player (2021-2026)
3.2 Global CAR-T Cell Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T CELL THERAPY DRUGS BY REGION
4.1 CAR-T Cell Therapy Drugs Market Size by Region (2021-2026)
4.2 Global CAR-T Cell Therapy Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
4.4 APAC CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
4.5 Europe CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-T Cell Therapy Drugs Market Size by Country (2021-2026)
5.2 Americas CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
5.3 Americas CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cell Therapy Drugs Market Size by Region (2021-2026)
6.2 APAC CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
6.3 APAC CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-T Cell Therapy Drugs Market Size by Country (2021-2026)
7.2 Europe CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
7.3 Europe CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Cell Therapy Drugs by Region (2021-2026)
8.2 Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
8.3 Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-T CELL THERAPY DRUGS MARKET FORECAST
10.1 Global CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.1.1 Global CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.1.2 Americas CAR-T Cell Therapy Drugs Forecast
10.1.3 APAC CAR-T Cell Therapy Drugs Forecast
10.1.4 Europe CAR-T Cell Therapy Drugs Forecast
10.1.5 Middle East & Africa CAR-T Cell Therapy Drugs Forecast
10.2 Americas CAR-T Cell Therapy Drugs Forecast by Country (2027-2032)
10.2.1 United States Market CAR-T Cell Therapy Drugs Forecast
10.2.2 Canada Market CAR-T Cell Therapy Drugs Forecast
10.2.3 Mexico Market CAR-T Cell Therapy Drugs Forecast
10.2.4 Brazil Market CAR-T Cell Therapy Drugs Forecast
10.3 APAC CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.3.1 China CAR-T Cell Therapy Drugs Market Forecast
10.3.2 Japan Market CAR-T Cell Therapy Drugs Forecast
10.3.3 Korea Market CAR-T Cell Therapy Drugs Forecast
10.3.4 Southeast Asia Market CAR-T Cell Therapy Drugs Forecast
10.3.5 India Market CAR-T Cell Therapy Drugs Forecast
10.3.6 Australia Market CAR-T Cell Therapy Drugs Forecast
10.4 Europe CAR-T Cell Therapy Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-T Cell Therapy Drugs Forecast
10.4.2 France Market CAR-T Cell Therapy Drugs Forecast
10.4.3 UK Market CAR-T Cell Therapy Drugs Forecast
10.4.4 Italy Market CAR-T Cell Therapy Drugs Forecast
10.4.5 Russia Market CAR-T Cell Therapy Drugs Forecast
10.5 Middle East & Africa CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-T Cell Therapy Drugs Forecast
10.5.2 South Africa Market CAR-T Cell Therapy Drugs Forecast
10.5.3 Israel Market CAR-T Cell Therapy Drugs Forecast
10.5.4 Turkey Market CAR-T Cell Therapy Drugs Forecast
10.6 Global CAR-T Cell Therapy Drugs Forecast by Targets (2027-2032)
10.7 Global CAR-T Cell Therapy Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-T Cell Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR-T Cell Therapy Drugs Product Offered
11.1.3 Novartis CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma CAR-T Cell Therapy Drugs Product Offered
11.2.3 Kite Pharma CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Bristol Myers Squibb?BMS?
11.3.1 Bristol Myers Squibb?BMS? Company Information
11.3.2 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product Offered
11.3.3 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol Myers Squibb?BMS? Main Business Overview
11.3.5 Bristol Myers Squibb?BMS? Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences CAR-T Cell Therapy Drugs Product Offered
11.4.3 Gilead Sciences CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson CAR-T Cell Therapy Drugs Product Offered
11.5.3 Johnson & Johnson CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Legend Biotech
11.6.1 Legend Biotech Company Information
11.6.2 Legend Biotech CAR-T Cell Therapy Drugs Product Offered
11.6.3 Legend Biotech CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Legend Biotech Main Business Overview
11.6.5 Legend Biotech Latest Developments
11.7 Fosun Kite
11.7.1 Fosun Kite Company Information
11.7.2 Fosun Kite CAR-T Cell Therapy Drugs Product Offered
11.7.3 Fosun Kite CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Fosun Kite Main Business Overview
11.7.5 Fosun Kite Latest Developments
11.8 JW Therapeutics
11.8.1 JW Therapeutics Company Information
11.8.2 JW Therapeutics CAR-T Cell Therapy Drugs Product Offered
11.8.3 JW Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 JW Therapeutics Main Business Overview
11.8.5 JW Therapeutics Latest Developments
11.9 IASO Biotherapeutics
11.9.1 IASO Biotherapeutics Company Information
11.9.2 IASO Biotherapeutics CAR-T Cell Therapy Drugs Product Offered
11.9.3 IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 IASO Biotherapeutics Main Business Overview
11.9.5 IASO Biotherapeutics Latest Developments
11.10 Juventas Cell Therapy
11.10.1 Juventas Cell Therapy Company Information
11.10.2 Juventas Cell Therapy CAR-T Cell Therapy Drugs Product Offered
11.10.3 Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Juventas Cell Therapy Main Business Overview
11.10.5 Juventas Cell Therapy Latest Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Information
11.11.2 CARsgen Therapeutics CAR-T Cell Therapy Drugs Product Offered
11.11.3 CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CARsgen Therapeutics Main Business Overview
11.11.5 CARsgen Therapeutics Latest Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Information
11.12.2 Bluebird Bio CAR-T Cell Therapy Drugs Product Offered
11.12.3 Bluebird Bio CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bluebird Bio Main Business Overview
11.12.5 Bluebird Bio Latest Developments
11.13 Curocell
11.13.1 Curocell Company Information
11.13.2 Curocell CAR-T Cell Therapy Drugs Product Offered
11.13.3 Curocell CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Curocell Main Business Overview
11.13.5 Curocell Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Cell Therapy Drugs Market Size (2021-2032)
2.1.2 CAR-T Cell Therapy Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-T Cell Therapy Drugs by Country/Region (2021, 2025 & 2032)
2.2 CAR-T Cell Therapy Drugs Segment by Targets
2.2.1 CD19 CAR-T
2.2.2 BCMA CAR-T
2.2.3 CD22 CAR-T
2.2.4 Dual-target CAR-T
2.2.5 CAR-T Cell Therapy Drugs Market Size by Targets
2.2.5.1 CAR-T Cell Therapy Drugs Market Size CAGR by Targets (2021 VS 2025 VS 2032)
2.2.5.2 Global CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
2.3 CAR-T Cell Therapy Drugs Segment by Cell Origin
2.3.1 Autologous CAR-T
2.3.2 Universal CAR-T
2.3.3 CAR-T Cell Therapy Drugs Market Size by Cell Origin
2.3.3.1 CAR-T Cell Therapy Drugs Market Size CAGR by Cell Origin (2021 VS 2025 VS 2032)
2.3.3.2 Global CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2021-2026)
2.4 CAR-T Cell Therapy Drugs Segment by Application
2.4.1 Hematologic Malignancies
2.4.2 Solid Tumors
2.4.3 Autoimmune Diseases
2.4.4 CAR-T Cell Therapy Drugs Market Size by Application
2.4.4.1 CAR-T Cell Therapy Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.4.2 Global CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
3 CAR-T CELL THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 CAR-T Cell Therapy Drugs Market Size Market Share by Player
3.1.1 Global CAR-T Cell Therapy Drugs Revenue by Player (2021-2026)
3.1.2 Global CAR-T Cell Therapy Drugs Revenue Market Share by Player (2021-2026)
3.2 Global CAR-T Cell Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T CELL THERAPY DRUGS BY REGION
4.1 CAR-T Cell Therapy Drugs Market Size by Region (2021-2026)
4.2 Global CAR-T Cell Therapy Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
4.4 APAC CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
4.5 Europe CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-T Cell Therapy Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-T Cell Therapy Drugs Market Size by Country (2021-2026)
5.2 Americas CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
5.3 Americas CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cell Therapy Drugs Market Size by Region (2021-2026)
6.2 APAC CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
6.3 APAC CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-T Cell Therapy Drugs Market Size by Country (2021-2026)
7.2 Europe CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
7.3 Europe CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Cell Therapy Drugs by Region (2021-2026)
8.2 Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
8.3 Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-T CELL THERAPY DRUGS MARKET FORECAST
10.1 Global CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.1.1 Global CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.1.2 Americas CAR-T Cell Therapy Drugs Forecast
10.1.3 APAC CAR-T Cell Therapy Drugs Forecast
10.1.4 Europe CAR-T Cell Therapy Drugs Forecast
10.1.5 Middle East & Africa CAR-T Cell Therapy Drugs Forecast
10.2 Americas CAR-T Cell Therapy Drugs Forecast by Country (2027-2032)
10.2.1 United States Market CAR-T Cell Therapy Drugs Forecast
10.2.2 Canada Market CAR-T Cell Therapy Drugs Forecast
10.2.3 Mexico Market CAR-T Cell Therapy Drugs Forecast
10.2.4 Brazil Market CAR-T Cell Therapy Drugs Forecast
10.3 APAC CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.3.1 China CAR-T Cell Therapy Drugs Market Forecast
10.3.2 Japan Market CAR-T Cell Therapy Drugs Forecast
10.3.3 Korea Market CAR-T Cell Therapy Drugs Forecast
10.3.4 Southeast Asia Market CAR-T Cell Therapy Drugs Forecast
10.3.5 India Market CAR-T Cell Therapy Drugs Forecast
10.3.6 Australia Market CAR-T Cell Therapy Drugs Forecast
10.4 Europe CAR-T Cell Therapy Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-T Cell Therapy Drugs Forecast
10.4.2 France Market CAR-T Cell Therapy Drugs Forecast
10.4.3 UK Market CAR-T Cell Therapy Drugs Forecast
10.4.4 Italy Market CAR-T Cell Therapy Drugs Forecast
10.4.5 Russia Market CAR-T Cell Therapy Drugs Forecast
10.5 Middle East & Africa CAR-T Cell Therapy Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-T Cell Therapy Drugs Forecast
10.5.2 South Africa Market CAR-T Cell Therapy Drugs Forecast
10.5.3 Israel Market CAR-T Cell Therapy Drugs Forecast
10.5.4 Turkey Market CAR-T Cell Therapy Drugs Forecast
10.6 Global CAR-T Cell Therapy Drugs Forecast by Targets (2027-2032)
10.7 Global CAR-T Cell Therapy Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-T Cell Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR-T Cell Therapy Drugs Product Offered
11.1.3 Novartis CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma CAR-T Cell Therapy Drugs Product Offered
11.2.3 Kite Pharma CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Bristol Myers Squibb?BMS?
11.3.1 Bristol Myers Squibb?BMS? Company Information
11.3.2 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product Offered
11.3.3 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol Myers Squibb?BMS? Main Business Overview
11.3.5 Bristol Myers Squibb?BMS? Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences CAR-T Cell Therapy Drugs Product Offered
11.4.3 Gilead Sciences CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson CAR-T Cell Therapy Drugs Product Offered
11.5.3 Johnson & Johnson CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Legend Biotech
11.6.1 Legend Biotech Company Information
11.6.2 Legend Biotech CAR-T Cell Therapy Drugs Product Offered
11.6.3 Legend Biotech CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Legend Biotech Main Business Overview
11.6.5 Legend Biotech Latest Developments
11.7 Fosun Kite
11.7.1 Fosun Kite Company Information
11.7.2 Fosun Kite CAR-T Cell Therapy Drugs Product Offered
11.7.3 Fosun Kite CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Fosun Kite Main Business Overview
11.7.5 Fosun Kite Latest Developments
11.8 JW Therapeutics
11.8.1 JW Therapeutics Company Information
11.8.2 JW Therapeutics CAR-T Cell Therapy Drugs Product Offered
11.8.3 JW Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 JW Therapeutics Main Business Overview
11.8.5 JW Therapeutics Latest Developments
11.9 IASO Biotherapeutics
11.9.1 IASO Biotherapeutics Company Information
11.9.2 IASO Biotherapeutics CAR-T Cell Therapy Drugs Product Offered
11.9.3 IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 IASO Biotherapeutics Main Business Overview
11.9.5 IASO Biotherapeutics Latest Developments
11.10 Juventas Cell Therapy
11.10.1 Juventas Cell Therapy Company Information
11.10.2 Juventas Cell Therapy CAR-T Cell Therapy Drugs Product Offered
11.10.3 Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Juventas Cell Therapy Main Business Overview
11.10.5 Juventas Cell Therapy Latest Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Information
11.11.2 CARsgen Therapeutics CAR-T Cell Therapy Drugs Product Offered
11.11.3 CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CARsgen Therapeutics Main Business Overview
11.11.5 CARsgen Therapeutics Latest Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Information
11.12.2 Bluebird Bio CAR-T Cell Therapy Drugs Product Offered
11.12.3 Bluebird Bio CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bluebird Bio Main Business Overview
11.12.5 Bluebird Bio Latest Developments
11.13 Curocell
11.13.1 Curocell Company Information
11.13.2 Curocell CAR-T Cell Therapy Drugs Product Offered
11.13.3 Curocell CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Curocell Main Business Overview
11.13.5 Curocell Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR-T Cell Therapy Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-T Cell Therapy Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CD19 CAR-T
Table 4. Major Players of BCMA CAR-T
Table 5. Major Players of CD22 CAR-T
Table 6. Major Players of Dual-target CAR-T
Table 7. CAR-T Cell Therapy Drugs Market Size CAGR by Targets (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 9. Global CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Table 10. Major Players of Autologous CAR-T
Table 11. Major Players of Universal CAR-T
Table 12. CAR-T Cell Therapy Drugs Market Size CAGR by Cell Origin (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global CAR-T Cell Therapy Drugs Market Size by Cell Origin (2021-2026) & ($ millions)
Table 14. Global CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2021-2026)
Table 15. CAR-T Cell Therapy Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 17. Global CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Table 18. Global CAR-T Cell Therapy Drugs Revenue by Player (2021-2026) & ($ millions)
Table 19. Global CAR-T Cell Therapy Drugs Revenue Market Share by Player (2021-2026)
Table 20. CAR-T Cell Therapy Drugs Key Players Head office and Products Offered
Table 21. CAR-T Cell Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global CAR-T Cell Therapy Drugs Market Size by Region (2021-2026) & ($ millions)
Table 25. Global CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Table 26. Global CAR-T Cell Therapy Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 27. Global CAR-T Cell Therapy Drugs Revenue Market Share by Country/Region (2021-2026)
Table 28. Americas CAR-T Cell Therapy Drugs Market Size by Country (2021-2026) & ($ millions)
Table 29. Americas CAR-T Cell Therapy Drugs Market Size Market Share by Country (2021-2026)
Table 30. Americas CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 31. Americas CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Table 32. Americas CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 33. Americas CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Table 34. APAC CAR-T Cell Therapy Drugs Market Size by Region (2021-2026) & ($ millions)
Table 35. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Table 36. APAC CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 37. APAC CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Europe CAR-T Cell Therapy Drugs Market Size by Country (2021-2026) & ($ millions)
Table 39. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Country (2021-2026)
Table 40. Europe CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 41. Europe CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Region (2021-2026) & ($ millions)
Table 43. Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 44. Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 45. Key Market Drivers & Growth Opportunities of CAR-T Cell Therapy Drugs
Table 46. Key Market Challenges & Risks of CAR-T Cell Therapy Drugs
Table 47. Key Industry Trends of CAR-T Cell Therapy Drugs
Table 48. Global CAR-T Cell Therapy Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 49. Global CAR-T Cell Therapy Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 50. Global CAR-T Cell Therapy Drugs Market Size Forecast by Targets (2027-2032) & ($ millions)
Table 51. Global CAR-T Cell Therapy Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 52. Novartis Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 53. Novartis CAR-T Cell Therapy Drugs Product Offered
Table 54. Novartis CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Kite Pharma Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 58. Kite Pharma CAR-T Cell Therapy Drugs Product Offered
Table 59. Kite Pharma CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Kite Pharma Main Business
Table 61. Kite Pharma Latest Developments
Table 62. Bristol Myers Squibb?BMS? Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 63. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product Offered
Table 64. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Bristol Myers Squibb?BMS? Main Business
Table 66. Bristol Myers Squibb?BMS? Latest Developments
Table 67. Gilead Sciences Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 68. Gilead Sciences CAR-T Cell Therapy Drugs Product Offered
Table 69. Gilead Sciences CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Gilead Sciences Main Business
Table 71. Gilead Sciences Latest Developments
Table 72. Johnson & Johnson Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 73. Johnson & Johnson CAR-T Cell Therapy Drugs Product Offered
Table 74. Johnson & Johnson CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments
Table 77. Legend Biotech Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 78. Legend Biotech CAR-T Cell Therapy Drugs Product Offered
Table 79. Legend Biotech CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Legend Biotech Main Business
Table 81. Legend Biotech Latest Developments
Table 82. Fosun Kite Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 83. Fosun Kite CAR-T Cell Therapy Drugs Product Offered
Table 84. Fosun Kite CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Fosun Kite Main Business
Table 86. Fosun Kite Latest Developments
Table 87. JW Therapeutics Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 88. JW Therapeutics CAR-T Cell Therapy Drugs Product Offered
Table 89. JW Therapeutics CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. JW Therapeutics Main Business
Table 91. JW Therapeutics Latest Developments
Table 92. IASO Biotherapeutics Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 93. IASO Biotherapeutics CAR-T Cell Therapy Drugs Product Offered
Table 94. IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. IASO Biotherapeutics Main Business
Table 96. IASO Biotherapeutics Latest Developments
Table 97. Juventas Cell Therapy Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 98. Juventas Cell Therapy CAR-T Cell Therapy Drugs Product Offered
Table 99. Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Juventas Cell Therapy Main Business
Table 101. Juventas Cell Therapy Latest Developments
Table 102. CARsgen Therapeutics Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 103. CARsgen Therapeutics CAR-T Cell Therapy Drugs Product Offered
Table 104. CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. CARsgen Therapeutics Main Business
Table 106. CARsgen Therapeutics Latest Developments
Table 107. Bluebird Bio Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 108. Bluebird Bio CAR-T Cell Therapy Drugs Product Offered
Table 109. Bluebird Bio CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Bluebird Bio Main Business
Table 111. Bluebird Bio Latest Developments
Table 112. Curocell Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 113. Curocell CAR-T Cell Therapy Drugs Product Offered
Table 114. Curocell CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Curocell Main Business
Table 116. Curocell Latest Developments
Table 1. CAR-T Cell Therapy Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-T Cell Therapy Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CD19 CAR-T
Table 4. Major Players of BCMA CAR-T
Table 5. Major Players of CD22 CAR-T
Table 6. Major Players of Dual-target CAR-T
Table 7. CAR-T Cell Therapy Drugs Market Size CAGR by Targets (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 9. Global CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Table 10. Major Players of Autologous CAR-T
Table 11. Major Players of Universal CAR-T
Table 12. CAR-T Cell Therapy Drugs Market Size CAGR by Cell Origin (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global CAR-T Cell Therapy Drugs Market Size by Cell Origin (2021-2026) & ($ millions)
Table 14. Global CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2021-2026)
Table 15. CAR-T Cell Therapy Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 17. Global CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Table 18. Global CAR-T Cell Therapy Drugs Revenue by Player (2021-2026) & ($ millions)
Table 19. Global CAR-T Cell Therapy Drugs Revenue Market Share by Player (2021-2026)
Table 20. CAR-T Cell Therapy Drugs Key Players Head office and Products Offered
Table 21. CAR-T Cell Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global CAR-T Cell Therapy Drugs Market Size by Region (2021-2026) & ($ millions)
Table 25. Global CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Table 26. Global CAR-T Cell Therapy Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 27. Global CAR-T Cell Therapy Drugs Revenue Market Share by Country/Region (2021-2026)
Table 28. Americas CAR-T Cell Therapy Drugs Market Size by Country (2021-2026) & ($ millions)
Table 29. Americas CAR-T Cell Therapy Drugs Market Size Market Share by Country (2021-2026)
Table 30. Americas CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 31. Americas CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Table 32. Americas CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 33. Americas CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Table 34. APAC CAR-T Cell Therapy Drugs Market Size by Region (2021-2026) & ($ millions)
Table 35. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Table 36. APAC CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 37. APAC CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Europe CAR-T Cell Therapy Drugs Market Size by Country (2021-2026) & ($ millions)
Table 39. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Country (2021-2026)
Table 40. Europe CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 41. Europe CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Region (2021-2026) & ($ millions)
Table 43. Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026) & ($ millions)
Table 44. Middle East & Africa CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & ($ millions)
Table 45. Key Market Drivers & Growth Opportunities of CAR-T Cell Therapy Drugs
Table 46. Key Market Challenges & Risks of CAR-T Cell Therapy Drugs
Table 47. Key Industry Trends of CAR-T Cell Therapy Drugs
Table 48. Global CAR-T Cell Therapy Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 49. Global CAR-T Cell Therapy Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 50. Global CAR-T Cell Therapy Drugs Market Size Forecast by Targets (2027-2032) & ($ millions)
Table 51. Global CAR-T Cell Therapy Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 52. Novartis Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 53. Novartis CAR-T Cell Therapy Drugs Product Offered
Table 54. Novartis CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Kite Pharma Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 58. Kite Pharma CAR-T Cell Therapy Drugs Product Offered
Table 59. Kite Pharma CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Kite Pharma Main Business
Table 61. Kite Pharma Latest Developments
Table 62. Bristol Myers Squibb?BMS? Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 63. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product Offered
Table 64. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Bristol Myers Squibb?BMS? Main Business
Table 66. Bristol Myers Squibb?BMS? Latest Developments
Table 67. Gilead Sciences Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 68. Gilead Sciences CAR-T Cell Therapy Drugs Product Offered
Table 69. Gilead Sciences CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Gilead Sciences Main Business
Table 71. Gilead Sciences Latest Developments
Table 72. Johnson & Johnson Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 73. Johnson & Johnson CAR-T Cell Therapy Drugs Product Offered
Table 74. Johnson & Johnson CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments
Table 77. Legend Biotech Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 78. Legend Biotech CAR-T Cell Therapy Drugs Product Offered
Table 79. Legend Biotech CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Legend Biotech Main Business
Table 81. Legend Biotech Latest Developments
Table 82. Fosun Kite Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 83. Fosun Kite CAR-T Cell Therapy Drugs Product Offered
Table 84. Fosun Kite CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Fosun Kite Main Business
Table 86. Fosun Kite Latest Developments
Table 87. JW Therapeutics Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 88. JW Therapeutics CAR-T Cell Therapy Drugs Product Offered
Table 89. JW Therapeutics CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. JW Therapeutics Main Business
Table 91. JW Therapeutics Latest Developments
Table 92. IASO Biotherapeutics Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 93. IASO Biotherapeutics CAR-T Cell Therapy Drugs Product Offered
Table 94. IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. IASO Biotherapeutics Main Business
Table 96. IASO Biotherapeutics Latest Developments
Table 97. Juventas Cell Therapy Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 98. Juventas Cell Therapy CAR-T Cell Therapy Drugs Product Offered
Table 99. Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Juventas Cell Therapy Main Business
Table 101. Juventas Cell Therapy Latest Developments
Table 102. CARsgen Therapeutics Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 103. CARsgen Therapeutics CAR-T Cell Therapy Drugs Product Offered
Table 104. CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. CARsgen Therapeutics Main Business
Table 106. CARsgen Therapeutics Latest Developments
Table 107. Bluebird Bio Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 108. Bluebird Bio CAR-T Cell Therapy Drugs Product Offered
Table 109. Bluebird Bio CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Bluebird Bio Main Business
Table 111. Bluebird Bio Latest Developments
Table 112. Curocell Details, Company Type, CAR-T Cell Therapy Drugs Area Served and Its Competitors
Table 113. Curocell CAR-T Cell Therapy Drugs Product Offered
Table 114. Curocell CAR-T Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Curocell Main Business
Table 116. Curocell Latest Developments
LIST OF FIGURES
Figure 1. CAR-T Cell Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Cell Therapy Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-T Cell Therapy Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-T Cell Therapy Drugs Sales Market Share by Country/Region (2025)
Figure 8. CAR-T Cell Therapy Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-T Cell Therapy Drugs Market Size Market Share by Targets in 2025
Figure 10. Global CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin in 2025
Figure 11. CAR-T Cell Therapy Drugs in Hematologic Malignancies
Figure 12. Global CAR-T Cell Therapy Drugs Market: Hematologic Malignancies (2021-2026) & ($ millions)
Figure 13. CAR-T Cell Therapy Drugs in Solid Tumors
Figure 14. Global CAR-T Cell Therapy Drugs Market: Solid Tumors (2021-2026) & ($ millions)
Figure 15. CAR-T Cell Therapy Drugs in Autoimmune Diseases
Figure 16. Global CAR-T Cell Therapy Drugs Market: Autoimmune Diseases (2021-2026) & ($ millions)
Figure 17. Global CAR-T Cell Therapy Drugs Market Size Market Share by Application in 2025
Figure 18. Global CAR-T Cell Therapy Drugs Revenue Market Share by Player in 2025
Figure 19. Global CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Figure 20. Americas CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 21. APAC CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 22. Europe CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 23. Middle East & Africa CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 24. Americas CAR-T Cell Therapy Drugs Value Market Share by Country in 2025
Figure 25. United States CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Canada CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Mexico CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. Brazil CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 29. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Region in 2025
Figure 30. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Figure 31. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Figure 32. China CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. Japan CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. South Korea CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Southeast Asia CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. India CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Australia CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 38. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Country in 2025
Figure 39. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Figure 40. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Figure 41. Germany CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. France CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. UK CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Italy CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Russia CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 46. Middle East & Africa CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Figure 47. Middle East & Africa CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Figure 48. Middle East & Africa CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Figure 49. Egypt CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. South Africa CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Israel CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Turkey CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. GCC Countries CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 54. Americas CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 55. APAC CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 56. Europe CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 57. Middle East & Africa CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 58. United States CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 59. Canada CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 60. Mexico CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 61. Brazil CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 62. China CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 63. Japan CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 64. Korea CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 65. Southeast Asia CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 66. India CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 67. Australia CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 68. Germany CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 69. France CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 70. UK CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 71. Italy CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 72. Russia CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 73. Egypt CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 74. South Africa CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 75. Israel CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 76. Turkey CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 77. Global CAR-T Cell Therapy Drugs Market Size Market Share Forecast by Targets (2027-2032)
Figure 78. Global CAR-T Cell Therapy Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 79. GCC Countries CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 1. CAR-T Cell Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Cell Therapy Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-T Cell Therapy Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-T Cell Therapy Drugs Sales Market Share by Country/Region (2025)
Figure 8. CAR-T Cell Therapy Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-T Cell Therapy Drugs Market Size Market Share by Targets in 2025
Figure 10. Global CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin in 2025
Figure 11. CAR-T Cell Therapy Drugs in Hematologic Malignancies
Figure 12. Global CAR-T Cell Therapy Drugs Market: Hematologic Malignancies (2021-2026) & ($ millions)
Figure 13. CAR-T Cell Therapy Drugs in Solid Tumors
Figure 14. Global CAR-T Cell Therapy Drugs Market: Solid Tumors (2021-2026) & ($ millions)
Figure 15. CAR-T Cell Therapy Drugs in Autoimmune Diseases
Figure 16. Global CAR-T Cell Therapy Drugs Market: Autoimmune Diseases (2021-2026) & ($ millions)
Figure 17. Global CAR-T Cell Therapy Drugs Market Size Market Share by Application in 2025
Figure 18. Global CAR-T Cell Therapy Drugs Revenue Market Share by Player in 2025
Figure 19. Global CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Figure 20. Americas CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 21. APAC CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 22. Europe CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 23. Middle East & Africa CAR-T Cell Therapy Drugs Market Size 2021-2026 ($ millions)
Figure 24. Americas CAR-T Cell Therapy Drugs Value Market Share by Country in 2025
Figure 25. United States CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Canada CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Mexico CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. Brazil CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 29. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Region in 2025
Figure 30. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Figure 31. APAC CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Figure 32. China CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. Japan CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. South Korea CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Southeast Asia CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. India CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Australia CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 38. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Country in 2025
Figure 39. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Figure 40. Europe CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Figure 41. Germany CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. France CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. UK CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Italy CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Russia CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 46. Middle East & Africa CAR-T Cell Therapy Drugs Market Size Market Share by Region (2021-2026)
Figure 47. Middle East & Africa CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2026)
Figure 48. Middle East & Africa CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2026)
Figure 49. Egypt CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. South Africa CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Israel CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Turkey CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. GCC Countries CAR-T Cell Therapy Drugs Market Size Growth 2021-2026 ($ millions)
Figure 54. Americas CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 55. APAC CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 56. Europe CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 57. Middle East & Africa CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 58. United States CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 59. Canada CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 60. Mexico CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 61. Brazil CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 62. China CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 63. Japan CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 64. Korea CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 65. Southeast Asia CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 66. India CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 67. Australia CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 68. Germany CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 69. France CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 70. UK CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 71. Italy CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 72. Russia CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 73. Egypt CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 74. South Africa CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 75. Israel CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 76. Turkey CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
Figure 77. Global CAR-T Cell Therapy Drugs Market Size Market Share Forecast by Targets (2027-2032)
Figure 78. Global CAR-T Cell Therapy Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 79. GCC Countries CAR-T Cell Therapy Drugs Market Size 2027-2032 ($ millions)
